6-氯嘧啶-4,5-二胺, 99%,6-Chloro-4,5-diaminopyrimidine

产品编号:西域试剂-WR342001| CAS NO:4316-98-7| MDL NO:MFCD00023270| 分子式:C4H5ClN4| 分子量:144.56

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
西域试剂-WR342001
44.00 杭州 北京(现货)
西域试剂-WR342001
118.00 杭州 北京(现货)
西域试剂-WR342001
457.00 杭州 北京(现货)
西域试剂-WR342001
2182.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

英文名称6-Chloro-4,5-diaminopyrimidine
CAS编号4316-98-7
产品熔点259 °C(dec.)
产品沸点336.7±37.0 °C at 760 mmHg
产品密度1.6±0.1 g/cm3
产品闪点157.4±26.5 °C
精确质量144.020279
PSA77.82000
LogP1.38
外观性状固体;White to Amber to Dark green powder to crystal
蒸气压0.0±0.7 mmHg at 25°C
折射率1.702
储存条件存放于惰性气体之中;避免空气

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


风险声明 (欧洲) 36/37/38
安全声明 (欧洲) 26-36
海关编码 2933599090
Material Safety Data Sheet

Section1. Identification of the substance
Product Name: 6-Chloropyrimidine-4,5-diamine
Synonyms:

Section2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section3. Composition/information on ingredients.
Ingredient name:6-Chloropyrimidine-4,5-diamine
CAS number:4316-98-7

Section4. First aid measures
Skin contact:Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact:Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation:Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion:Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution:Wear approved mask/respirator
Hand precaution:Wear suitable gloves/gauntlets
Skin protection:Wear suitable protective clothing
Eye protection:Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section7. Handling and storage
Handling:This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section9. Physical and chemical properties
Appearance:Not specified
Boiling point:No data
No data
Melting point:
Flash point:No data
Density:No data
Molecular formula:C4H5ClN4
Molecular weight:144.6

Section10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section11. Toxicological information
No data.

Section12. Ecological information
No data.

Section13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section14. Transportation information
Non-harzardous for air and ground transportation.

Section15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

~99%

4316-98-7结构式

4316-98-7

文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2007/125325 A1, 2007 ; Location in patent: Page/Page column 92-93 ; WO 2007/125325 A1

~65%

4316-98-7结构式

4316-98-7

文献:Baraldi, Pier Giovanni; Broceta, Asier Unciti; Infantas, Maria Jose Pineda De Las; Mochun, Juan Jose Diaz; Espinosa, Antonio; Romagnoli, Romeo Tetrahedron, 2002 , vol. 58, # 38 p. 7607 - 7611

~14%

4316-98-7结构式

4316-98-7

文献:ASTRAZENECA AB; ASTRAZENECA UK LIMITED Patent: WO2004/13141 A1, 2004 ; Location in patent: Page 134 ; WO 2004/013141 A1

服务热线

13911702513
18601927057

微信客服